Literature DB >> 32984438

Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management.

Akash Mukherjee1, Ibrahim F Ibrahim2.   

Abstract

Entities:  

Year:  2018        PMID： 32984438      PMCID： PMC7518387          DOI： 10.12788/jcso.0425

Source DB:  PubMed          Journal:  J Community Support Oncol        ISSN： 2330-7749


× No keyword cloud information.
  9 in total

1.  Fluorodeoxyglucose-PET/CT for diagnosis of intravascular large B-cell lymphoma.

Authors:  Yasuo Miura; Mitsuru Tsudo
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

2.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Elías Campo; Fabio Facchetti; Luca Mazzucchelli; Tadashi Yoshino; Takuhei Murase; Stefano A Pileri; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Shigeo Nakamura
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

Review 3.  Presentation and management of intravascular large B-cell lymphoma.

Authors:  Kazuyuki Shimada; Tomohiro Kinoshita; Tomoki Naoe; Shigeo Nakamura
Journal:  Lancet Oncol       Date:  2009-09       Impact factor: 41.316

Review 4.  Intravascular large B-cell lymphoma.

Authors:  Dennis E Orwat; Nicholas I Batalis
Journal:  Arch Pathol Lab Med       Date:  2012-03       Impact factor: 5.534

5.  Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma.

Authors:  K Kato; Y Ohno; T Kamimura; H Kusumoto; T Tochigi; F Jinnouchi; K Kohno; T Kuriyama; H Henzan; K Takase; I Kawano; M Kadowaki; R Nawata; T Muta; T Eto; H Iawasaki; K Ohshima; T Miyamoto; K Akashi
Journal:  Bone Marrow Transplant       Date:  2014-08-18       Impact factor: 5.483

6.  Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

Authors:  Takuhei Murase; Motoko Yamaguchi; Ritsuro Suzuki; Masataka Okamoto; Yumiko Sato; Jun-ichi Tamaru; Masaru Kojima; Ikuo Miura; Naoyoshi Mori; Tadashi Yoshino; Shigeo Nakamura
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

Review 7.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

8.  Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Kazuyuki Shimada; Hiroshi Kosugi; Satoko Shimada; Hiroto Narimatsu; Yoshitsugu Koyama; Nobuaki Suzuki; Masaaki Yuge; Hironori Nishibori; Yosuke Iwata; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2008-05-22       Impact factor: 2.490

9.  Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.

Authors:  Kazuyuki Shimada; Kosei Matsue; Kazuhito Yamamoto; Takuhei Murase; Naoaki Ichikawa; Masataka Okamoto; Nozomi Niitsu; Hiroshi Kosugi; Norifumi Tsukamoto; Hiroshi Miwa; Hideki Asaoku; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.